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Abstract 
Piscine orthoreovirus (PRV) is associated with heart- and skeletal muscle inflammation in farmed Atlantic salmon. 
The virus is ubiquitous and found in both farmed and wild salmonid fish. It belongs to the family Reoviridae, closely 
related to the genus Orthoreovirus. The PRV genome comprises ten double-stranded RNA segments encoding at least 
eight structural and two non-structural proteins. Erythrocytes are the major target cells for PRV. Infected erythrocytes 
contain globular inclusions resembling viral factories; the putative site of viral replication. For the mammalian reovirus 
(MRV), the non-structural protein μNS is the primary organizer in factory formation. The analogous PRV protein was 
the focus of the present study. The subcellular location of PRV μNS and its co-localization with the PRV σNS, µ2 and λ1 
proteins was investigated. We demonstrated that PRV μNS forms dense globular cytoplasmic inclusions in transfected 
fish cells, resembling the viral factories of MRV. In co-transfection experiments with μNS, the σNS, μ2 and λ1 proteins 
were recruited to the globular structures. The ability of μNS to recruit other PRV proteins into globular inclusions indi-
cates that it is the main viral protein involved in viral factory formation and pivotal in early steps of viral assembly.
© 2016 Haatveit et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Piscine orthoreovirus (PRV) is a member of the family 
Reoviridae. The virus is associated with heart and skel-
etal muscle inflammation (HSMI), an important emerg-
ing disease in the intensive farming of Atlantic salmon 
(Salmo salar) [1, 2]. HSMI is mainly observed during the 
seawater grow-out phase and there is often a prolonged 
disease development [3]. The cumulative mortality var-
ies from negligible to 20%, while the morbidity is almost 
100% in affected cages [3]. PRV seems to be ubiquitous 
in Norwegian salmon farms [4]. Fish kept at high stock-
ing density with frequent handling experience a stress-
ful environment that may result in immunosuppression 
and a greater disease burden, thus facilitating the rapid 
spread of pathogens [5]. PRV has also been detected in 
wild salmon, but no lesions consistent with HSMI have 
been discovered in the wild population [6].
Phylogenetic analysis indicates that PRV branches 
off the common root of the genera Orthoreovirus and 
Aquareovirus, but most closely related to the orthoreo-
viruses [7, 8]. PRV differs from other orthoreoviruses 
like mammalian reoviruses (MRVs) and avian reoviruses 
(ARVs) in the ability to infect salmonid fish species at 
low temperatures, and in the preference for erythro-
cytes as one of the main target cells. The genome of PRV 
comprises ten double-stranded RNA (dsRNA) segments 
distributed in the classical orthoreoviral groups of three 
large, three medium and four small segments [1, 8, 9]. 
Currently, the PRV genome has been found to encode at 
least ten primary translation products. However, there 
is only a limited number of functional studies concern-
ing the different proteins expressed by this virus [10, 11]. 
Based upon sequence homology to MRV, and the pres-
ence of conserved structures and motifs, eight of the 
deduced translation products are assumed structural 
components forming the orthoreovirus particle with an 
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inner core and an outer capsid, while two of the transla-
tion products are non-structural proteins [8, 12].
A common feature for the non-structural proteins of 
reoviruses is their ability to form viral factories [13, 14]. 
Viral factories, also known as viroplasms or viral repli-
cation centers, are intracellular compartments for rep-
lication, packaging and assembly of viral particles [13, 
15]. Several RNA and DNA viruses have been reported 
to induce these specialized membranous compartments 
within the cytoplasm of infected cells [16–18]. They 
commonly form as invaginations in a variety of orga-
nelles such as mitochondria, endoplasmic reticulum, 
lysosomes, peroxisomes, Golgi apparatus or chloroplasts 
[18, 19]. The factory scaffold facilitates spatial coordina-
tion of viral genome replication and assembly with the 
use of cell resources [18]. The viral factory inclusions 
seen during MRV infection consist of viral dsRNA, viral 
proteins, partially and fully assembled viral particles, 
microtubules and thinner filaments suggested to be inter-
mediate structures [20]. Although organization of viral 
factories varies between different virus families, several 
fundamental similarities exist. Viruses utilize cellular bio-
synthetic pathways for their morphogenesis and propa-
gation, and use a variety of mechanisms to avoid being 
wiped out by the cellular antiviral response [13, 21]. In 
the viral factories the viral pathogen-associated molecu-
lar patterns are shielded from inducing the activation of 
cellular innate responses [19].
Erythrocytes are major target cells for PRV, and in 
infected erythrocytes globular inclusions are formed 
and contain both PRV protein and dsRNA [22, 23]. The 
inclusions resemble the globular viral factories seen in 
MRV type 3 Dearing (T3D) prototype strain infected 
cells [19, 22]. Furthermore, the PRV inclusions contain 
reovirus-like particles as observed by transmission elec-
tron microscopy (TEM) [22]. This suggests that PRV, like 
MRV, forms viral factories in infected cells.
MRV μNS is the scaffolding protein that organizes 
viral factories during MRV infection [24]. Comparison 
of the PRV μNS amino acid sequence with the homolo-
gous proteins from MRV and ARV has revealed a very 
low sequence identity of only 17%, however, partially 
conserved motifs are present [8]. The latter includes a 
C-terminal motif shown for MRV μNS to be required 
for the recruitment of clathrin to viral factories [8, 25]. 
Furthermore, predictions of MRV and ARV μNS show 
two α-helical coils in their C-terminal region required 
for inclusion formation [26–29]. A high α-helical con-
tent in the C-terminal region is also predicted for the 
PRV μNS, but coiled coil motifs are predicted with sig-
nificantly lower probability than for MRV and ARV [8]. 
In addition, MRV and ARV have both been shown to 
produce two protein products from gene segment M3 [8, 
30]. Whereas μNS represents the full-length isoform, a 
second in-frame AUG (Met41) in the MRV protein rep-
resents the translational start site for the second isoform 
μNSC. In the ARV protein, post-translational cleavage 
near the N-terminal region creates μNSN [8, 30]. In PRV 
M3, only one open reading frame (ORF) has been identi-
fied encoding the μNS protein [8].
We hypothesized that the μNS of PRV is an organiza-
tion center in the assembly of progeny virus particles. 
The aim in this study was to examine the localization of 
PRV μNS and its ability to interact with other PRV pro-
teins in transfected cells.
Materials and methods
Cells
EPC cells (ATCC CRL-2872, Epithelioma papulosum 
cyprini) and CHSE-214 cells (ATCC CRL-1681, Chinook 
salmon embryo) were cultivated in Leibovitz-15 medium 
(L15, Life Technologies, Paisley, Scotland, UK) supple-
mented with 10% heat inactivated fetal bovine serum 
(FBS, Life technologies), 2  mM  l-glutamine, 0.04  mM 
mercaptoethanol and 0.05  mg/mL gentamycin-sulphate 
(Life Technologies).
Computer analyses
Multiple sequence alignments were performed using 
AlignX (Vector NTI Advance™ 11, Invitrogen, Carlsbad, 
CA, USA) and protein secondary structure predictions 
using PSIPRED v3.0. The presence of putative nuclear 
localization signals (NLS) in PRV μ2 was investigated 
using PSORTII, PredictProtein [31] and NLS map-
per. The GenBank accession numbers for the PRV μNS, 
σNS, λ1 and μ2 coding sequences of the present study 
are KR337478, KR337481, KR337475 and KR337476, 
respectively.
Plasmid constructs
Total RNA was isolated from homogenized tissue from 
a natural outbreak of HSMI in Atlantic salmon (MH-
050607) as previously described [8]. RNA was denatured 
at 95  °C for 5  min and transcribed into cDNA using 
SuperScript® III Reverse Transcriptase (RT) (Invitro-
gen) and Random Primers (Invitrogen) according to the 
manufacturer’s protocol. PfuUltra II Fusion HS DNA 
polymerase (Agilent, Santa Clara, CA, USA) was used to 
amplify the ORFs of μNS, σNS, μ2 and λ1. The primers 
contained the sequences encoding flag-tag, myc-tag or 
HA-tag for protein recognition by antibodies [32]. Primer 
sequences are shown in Table 1. For both the full-length 
μNS and σNS constructs, a pair of expression vectors 
was made encoding proteins tagged in either the C-ter-
minus or the N-terminus; pcDNA3.1-μNS-N-FLAG, 
pcDNA3.1-μNS-C-FLAG, pcDNA3.1-σNS-N-MYC and 
Page 3 of 11Haatveit et al. Vet Res  (2016) 47:5 
pcDNA3.1-σNS-C-MYC. For μ2, the tag was added only 
C-terminally and for λ1 only N-terminally, pcDNA3.1-
μ2-C-MYC and pcDNA3.1-λ1-N-HA, respectively. Four 
truncated forms of the μNS protein with flag-tags C- or 
N-terminally depending on the truncation were also 
generated to determine sequence regions in PRV μNS 
involved in formation of viral factories during infec-
tion, pcDNA3.1-μNSΔ1-401, pcDNA3.1-μNSΔ402-752, 
pcDNA3.1-μNSΔ736-752 and pcDNA3.1-μNSΔ743-752 
(Figure 1). In-fusion HD Cloning Kit (Clontech Labora-
tories, Mountain View, CA, USA) was used to clone PCR 
products into the XbaI restriction site of the eukaryotic 
expression vector pcDNA3.1(+) (Invitrogen). Sanger 
sequencing (GATC Biotech AG, Konstanz, Germany) 
verified all sequences. A pcDNA3.1 construct express-
ing the protein encoded by infectious salmon anemia 
virus (ISAV) segment 8 open reading frame 2 (S8ORF2) 
protein [33] was used as a control during transfections, 
immunoprecipitation and western blotting. 
Transfections of fish cells
EPC and CHSE cells were seeded on gelatin embedded 
cover slips (12  mm) with pre-equilibrated L-15 growth 
medium at a density of 1.5  ×  104 cells in a 24-well 
plate 24 h prior to transfection. Plasmids were transfected 
using Lipofectamine LTX reagent (Life Technologies) 
according to the manufacturer’s instructions. In brief, 2 
μL lipofectamine was mixed with 0.5 μg plasmid and 0.5 
μL PLUS reagent, and diluted in a total of 100 μL Opti-
MEM (Life Technologies). After 5 min of incubation, the 
mixture was added to the cells and incubated at 20  °C 
for 48 h. When co-transfections were performed, a total 
of 0.4 μg of each plasmid were used and the amount of 
PLUS reagent was increased to 0.8 μL.
Immunofluorescence microscopy
Transfected EPC and CHSE cells were fixed and stained 
using an intracellular Fixation and Permeabilization 
Buffer (eBioscience, San Diego, CA, USA). The cells were 
washed in Dulbecco’s PBS (DPBS) with sodium azide. 
Intracellular fixation buffer was added before incubation 
Table 1 Expression plasmids.
Primers used in generating the constructs encoding PRV μNS (M3), σNS (S3), μ2 (M1) and λ1 (L3) and truncated versions of μNS.
Start codons are marked in bold and epitope tags in italic.
Plasmid name Primer Sequence (5ʹ → 3ʹ)
pcDNA3.1-μNS-N-FLAG Forward GCCGCTCGAGTCTAGAGCCACCATGGACTACAAAGACGATGACGACAAGATGGCTGAATCAATTACTTTTG
Reverse AAACGGGCCCTCTAGATCAGCCACGTAGCACATTATTCAC
pcDNA3.1-μNS-C-FLAG Forward GCCGCTCGAGTCTAGAGCCACCATGCGCAAGCTGGACTTGGTTGCA
Reverse AAACGGGCCCTCTAGATCACTTGTCGTCATCGTCTTTGTAGTCGCCACGTAGCACATTATTCACGCC
pcDNA3.1-σNS-N-MYC Forward GCCGCTCGAGTCTAGAGCCACCATGGAACAAAAACTCATCTCAGAAGAGGATCTGATGTCGAACTTTGATCTTGG
Reverse AAACGGGCCCTCTAGACTAACAAAACATGGCCATGA
pcDNA3.1-σNS-C-MYC Forward GCCGCTCGAGTCTAGAGCCACCATGTCGAACTTTGATCTTGG
Reverse AAACGGGCCCTCTAGACTACAGATCCTCTTCTGAGATGAGTTTTTGTTCACAAAACATGGCCATGATGC
pcDNA3.1-μ2-C-HA Forward GGCGGCCGCTCGAGTCTAGAATGCCTATCATAAACCTGCC
Reverse GTTTAAACGGGCCCTCTAGAAGCGTAATCTGGAACATCGTATGGGTACTCACCAGCTGTAGACCACC
pcDNA3.1- λ1-N-HA Forward CGCTCGAGTCTAGAGCCACCATGTACCCATACGATGTTCCAGATTACGCTATGGAGCGACTTAAGAGGAAAG
Reverse AAACGGGCCCTCTAGATTAGTTGAGTACAGGATGAG
pcDNA3.1-μNSΔ743-753 Forward GCCGCTCGAGTCTAGAGCCACCATGGACTACAAAGACGATGACGACAAGATGGCTGAATCAATTACTTTTG
Reverse AAACGGGCCCTCTAGATCACCAGTCATCTGAGCCACCAAA
pcDNA3.1-μNSΔ736-752 Forward GCCGCTCGAGTCTAGAGCCACCATGGACTACAAAGACGATGACGACAAGATGGCTGAATCAATTACTTTTG
Reverse AAACGGGCCCTCTAGATCAGTCGATGATTTTTGGAAACTC
pcDNA3.1-μNSΔ1-401 Forward GCCGCTCGAGTCTAGAGCCACCATGCCAACCACCTGGTATTCAAC
Reverse AAACGGGCCCTCTAGATCACTTGTCGTCATCGTCTTTGTAGTCGCCACGTAGCACATTATTCACGCC
pcDNA3.1-μNSΔ402-752 Forward GCCGCTCGAGTCTAGAGCCACCATGGACTACAAAGACGATGACGACAAGATGGCTGAATCAATTACTTTTG
Reverse AAACGGGCCCTCTAGATCATGTGGTCAGGGAATAGTGCAT
Figure 1 Truncated μNS variants. Schematic overview of the 
truncated μNS constructs.
Page 4 of 11Haatveit et al. Vet Res  (2016) 47:5 
with primary (1:1000) and secondary antibodies (1:400) 
diluted in permeabilization buffer according to the manu-
facturer’s protocol. Antibodies against flag (mouse anti-
flag antibody) and HA (rabbit anti-HA antibody) were 
obtained from Sigma-Aldrich (St Louis, MO, USA), 
while antibodies against the myc epitope (goat anti-myc 
antibody) was obtained from Abcam (Cambridge, UK). 
Secondary antibodies against mouse immunoglobulin 
G (IgG), goat IgG and rabbit IgG were conjugated with 
either Alexa Fluor 488 or 594 obtained from Molecular 
Probes (Life Technologies). Hoechst trihydrochloride tri-
hydrate (Life Technologies) was used for nuclear stain-
ing. The cover slips were mounted onto glass slides using 
Fluoroshield (Sigma-Aldrich) and prepared for micros-
copy as described above. Images were captured on an 
inverted fluorescence microscope (Olympus IX81) and on 
a confocal laser scanning microscope (Zeiss LSM 710).
Immunoprecipitation
A total of 5 million EPC cells were pelleted by centrifuga-
tion, resuspended in 100 μL Ingenio Electroporation Solu-
tion (Mirus, Madison, WI, USA) and co-transfected with 
8 μg plasmid using the Amaxa T-20 program. pcDNA3.1-
μNS-N-FLAG was co-transfected with pcDNA3.1-σNS-
N-MYC, pcDNA3.1-μ2-C-HA, pcDNA3.1-λ1-N-HA and 
pcDNA3.1 S8ORF2 (negative control) separately, using 
three parallel preparations. The transfected cells were 
transferred to 75  cm2 culture flasks containing 20  mL 
pre-equilibrated L-15 growth medium (described above). 
From each culture flask, 0.5  mL transfected cells were 
transferred to a 24-well plate intended for expression 
analysis by immunofluorescence microscopy. Cells were 
collected from the culture flasks 72  h post transfection 
(hpt), centrifuged at 5000 g for 5 min and resuspended in 
1 mL Nonidet-P40 lysis buffer (1% NP-40, 50 mM Tris–
HCl pH 8.0, 150  mM NaCl, 2  mM EDTA) containing 
Complete ultra mini protease inhibitor cocktail (Roche, 
Mannheim, Germany). The mix was incubated on ice for 
30 min, and then centrifuged at 9700 g for 12 min at 4 °C. 
The supernatant was transferred to a new tube, added 
antibodies against the desired epitope tag or anti-S8ORF2 
and incubated overnight at 4 °C with rotation. The Immu-
noprecipitation Kit Dynabeads Protein G (Novex, Life 
Technologies) was used for protein extraction and the 
beads prepared according to the manufacturer’s protocol. 
The cell-lysate-antibody mixture was mixed with the pro-
tein G coated beads and incubated 2 h at 4 °C. The beads-
antibody-protein complex was washed according to the 
manufacturer’s protocol.
Western blotting
The beads-antibody-protein complex was diluted in 
Sample Buffer (Bio-Rad, Hercules, CA, USA) and 
Reducing Agent (Bio-Rad), denatured for 5 min at 95 °C 
and run in sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis (SDS-PAGE), using 4-12% Bis–Tris Cri-
terion XT gel (Bio-Rad). Lysates from non-transfected 
EPC cells were used as a negative control, and Preci-
sion Plus Protein Western C Standards (Bio-Rad) as a 
molecular size marker. Following SDS-PAGE, the pro-
teins were blotted onto a polyvinylidene fluoride (PVDF) 
membrane (Bio-Rad) and incubated with primary anti-
body (anti-flag 1:1000) at 4  °C overnight. After incuba-
tion with secondary antibody (Anti-mouse IgG-HRP, 
GE Healthcare, Buchinghamshire, UK), the proteins 
were detected by chemiluminescense using Amersham 
ECL Prime Western Blotting Detection Reagent (GE 
Healthcare).
Results
Prediction of secondary structure
The predicted secondary structure profiles of PRV and 
MRV μNS were similar despite low sequence identity 
(Figure 2). The PRV μNS sequence in this study differs by 
twenty-three nucleotides of which twenty are silent (not 
shown) to that analyzed in a previous study (GU994018) 
[8]. The three amino acids that differed between the two 
PRV μNS sequences did not cause significant changes to 
the predicted secondary structures as determined by the 
PSIPRED program. The remaining three nucleotides all 
result in synonymous amino acid differences, i.e., display-
ing similar physiochemical properties (M/L94, I/V451 and 
A/V498). For σNS, the difference is six nucleotides and for 
λ1 twenty-eight, all silent. For μ2, the difference is fifteen 
nucleotides, all silent except for one synonymous substi-
tution (R/K113).
μNS forms viral factory‑like structures
EPC cells transfected with pcDNA3.1-μNS-N-FLAG 
48 hpt showed small, dense globular inclusions evenly 
distributed in the cytoplasm with some larger perinu-
clear inclusions 48 hpt (Figure  3A). A similar staining 
pattern was seen with the corresponding C-terminally 
flag-labelled construct (Figure 3A, insert), and in CHSE 
cells (not shown). EPC cells transfected with the σNS-N-
MYC, μ2-C-HA or λ1-N-HA constructs were also exam-
ined 48 hpt (Figure 3B–D). The σNS-N-MYC protein was 
evenly distributed in the cytoplasm possibly with some 
minor nuclear localization (Figure  3B). A nucleocyto-
plasmic distribution pattern was also observed with the 
C-terminally myc-labelled σNS (Figure 3B, insert). Both 
the μ2-C-HA and λ1-N-HA proteins were evenly distrib-
uted in the cytoplasm (Figure 3C and D), with the former 
showing minor staining in the nucleus of some cells (not 
shown). Non-transfected cells did not show any staining 
(not shown).
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Figure 2 Secondary structure predictions. Secondary structure predictions of the μNS proteins from PRV and MRV (PSIPRED). Accession num-
bers for the MRV and PRV proteins are NC004281 and KR337478, respectively.
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σNS, λ1 and μ2 are recruited to viral factory‑like structures
Viral proteins interacting with μNS were identified 
by co-transfecting EPC cells with pcDNA3.1-μNS-N-
FLAG and separately with each of the σNS-N-MYC, 
μ2-C-HA or λ1-N-HA constructs. The μNS protein 
retained its globular distribution pattern in the pres-
ence of the other PRV proteins 48 hpt (Figure  4). In 
contrast, the staining pattern for σNS, μ2 and λ1 pro-
teins changed from an evenly cytoplasmic distribution 
to globular inclusions co-localizing wholly or partially 
with the μNS protein (Figure  4A–C). Co-localization 
with μNS was most pronounced for σNS, and σNS was 
no longer found in the nucleus (Figure 4A). For μ2, the 
change in distribution was not as pronounced as for 
σNS and λ1, but in some cells μ2 formed small punc-
tuated structures partially overlapping with the μNS 
globular inclusions (Figure 4B). Co-expression of σNS-
N-MYC with either μ2-C-HA or λ1-N-HA, i.e. in the 
absence of μNS, did not alter staining patterns, and 
the viral factory-like structures were not formed (not 
shown).
σNS and μ2 interact with μNS
Immunoprecipitation and western blotting were per-
formed to confirm interactions between PRV μNS and 
each of σNS, λ1 and μ2 (Figure  5). EPC cells were co-
transfected with μNS-N-FLAG and separately with the 
σNS-N-MYC, λ1-N-HA and μ2-C-HA constructs. The 
results confirmed that μNS interacts with σNS and μ2. 
Interaction with λ1 on the other hand (Figure 5), or to the 
negative control ISAV-S8ORF2 protein, was not observed 
(not shown).
Figure 3 Subcellular localization of PRV proteins. EPC cells transfected with four different PRV plasmid constructs (µNS, σNS, λ1, µ2) processed 
for fluorescence microscopy 48 hpt. A EPC cells expressing μNS N-FLAG. Boxed region in top left corner shows EPC cells expressing μNS-C-FLAG. B 
EPC cells expressing σNS N-MYC. Boxed region shows σNS-C-MYC. C EPC cells expressing μ2-C-HA. D EPC cells expressing λ1-N-HA.
Page 7 of 11Haatveit et al. Vet Res  (2016) 47:5 
Truncated μNS proteins
EPC cells were transfected with plasmid constructs encod-
ing the truncated μNS variants μNS-Δ743-752, μNS-
Δ736-752, μNS-Δ1-401 and μNS-Δ402-752 (Figure  1). 
Small, factory-like globular inclusions were formed by 
μNSΔ743-752 and μNSΔ736-752 (Figure 6A and B). Indi-
vidual co-expression of these μNS truncated variants with 
σNS-N-MYC recruited the latter protein to the factory-
like inclusions, similar to that observed with full-length 
μNS (Figures  4A, 6A and B). The μNSΔ1-401 protein 
formed small dense irregular or granular structures in the 
cytoplasm with reminiscences to the globular structures 
formed by the full-length protein (Figure 6C). The μNSΔ1-
401 truncated version did also recruit and change the dis-
tribution pattern of σNS (Figures 3B and 6C). In contrast, 
μNSΔ402-752 was evenly distributed in the cytoplasm, and 
did not form viral factory-like structures. When μNSΔ402-
752 was expressed together with σNS, both proteins were 
evenly dispersed throughout the cytoplasm (Figure 6D).
Discussion
The reoviral factories are the sites for virus replica-
tion and particle assembly [19]. The MRV μNS is the 
scaffolding protein organizing the viral factories includ-
ing gathering of core proteins, while the σNS protein 
facilitates construction of core particles and subsequent 
particle assembly [20, 24, 29, 34]. Viral factory-like 
structures have been observed in PRV infected Atlantic 
salmon erythrocytes in both in vivo and ex vivo experi-
ments [22, 23]. In this study we demonstrated that 
PRV μNS alone forms dense globular, viral factory-like 
cytoplasmic inclusions. The globular, cytoplasmic dis-
tribution of μNS was not seen for the non-structural 
σNS or the structural μ2 and λ1 PRV proteins. How-
ever, these proteins changed their distribution pat-
tern and co-localized with μNS in the dense globular 
structures when they were co-transfected with μNS. 
Co-transfection of σNS with μ2 or λ1 did not cause 
changes in distribution pattern. Expression of the 
N-terminal 401 amino acids did not form viral factory-
like structures, mapping this feature to the remaining 
C-terminal 351 amino acids. Immunoprecipitation and 
subsequent Western blot analysis confirmed the asso-
ciation between μNS-σNS and μNS-μ2. Our findings 
strongly suggests that μNS is the prime organizer of 
viral factories for PRV.
Figure 4 Co-transfections with μNS. EPC cells transfected with constructs encoding σNS, μ2 and λ1 and co-transfected with µNS. The cells were 
processed for confocal microscopy 48 hpt. A EPC cells transfected with σNS alone and cotransfected with μNS. B EPC cells transfected with μ2 
alone and cotransfected with μNS. C EPC cells transfected with λ1 alone and cotransfected with μNS.
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MRV strains exhibit differences in viral inclusion mor-
phology. Reovirus type 1 Lang (T1L) forms filamentous 
inclusions, whereas type 3 Dearing (T3D) forms punctate 
or globular inclusions [20, 35]. These morphologic differ-
ences are determined by the ability of the virus to interact 
with the microtubule system, a feature mapped to MRV 
μ2 [35]. In the filamentous factories, μ2 co-localize with 
and stabilize microtubules when expressed in cells in the 
absence of other viral proteins [20, 35]. PRV inclusions 
appear similar to the globular inclusion type, closely 
resembling the μNS-containing globular viral factories in 
reovirus T3D infected cells [35]. We cannot exclude that 
there are strains of PRV that forms filamentous inclu-
sions. There might be several not yet recognized PRV-
like viruses that infect other salmonid fish species. It has 
been proposed that the larger surface area of filamen-
tous inclusions allow for more efficient viral replication 
through better access to small-molecule substrates or 
newly synthesized proteins from the surrounding cytosol 
[35]. Immunofluorescence and confocal microscopy have 
been used to identify globular and filamentous inclusions 
after transfection with expression plasmids encoding 
proteins from MRV and ARV [27, 36, 37].
Viral factories commonly form early in reovirus infec-
tion as small punctate structures throughout the cyto-
plasm that increase in size and become more perinuclear 
during infection [20]. The factories recruit viral proteins, 
which allow the efficient assembly of virus core particles 
[34, 38]. We observed that PRV μNS guided the σNS, μ2 
and λ1 proteins to the viral factories. Our rationale for 
choosing σNS, μ2 and λ1 as co-transfectants was that 
these are examples of non-structural (σNS) and struc-
tural (μ2 and λ1) proteins in the core particle. MRV μNS 
and σNS are found in the first detectable viral protein-
RNA complexes in MRV infected cells and form cytoplas-
mic inclusions similar to the viral factory-like structures 
formed in the absence of viral infection [36]. Analysis of 
MRV μNS transfected cells revealed that at 6 hpt, μNS 
inclusions were uniformly small and spread through-
out the cytoplasm, whereas at 18 hpt and 36 hpt, larger 
perinuclear inclusions were present along with smaller 
inclusions [20]. In addition to its association with σNS, 
MRV μNS has been shown to interact with each of the 
five structural proteins that make up the core particle (λ1, 
λ2, λ3, σ2 and μ2) [24, 34]. Although it generally occurs 
within 18 hpt, strong co-localization between MRV μNS 
and the core surface proteins have been observed as soon 
as 6 h post infection [34]. Since PRV replicates at lower 
temperatures than MRV, the process of assembling core 
proteins to viral factories occurs at a slower rate. Studies 
on the ARV have identified a similar role of μNS in form-
ing viral factories [27].
The nature of the globular inclusions and their inter-
actions with other PRV proteins might differ in eryth-
rocytes and established cell lines. However, neither cell 
line nor C– or N-terminal epitope tagging influenced the 
formation of dense globular structures by the PRV μNS. 
Transfection of salmon erythrocytes was not successful 
(data not shown). Still, globular-type inclusions are com-
mon in naturally PRV infected erythrocytes. This indi-
cates that the formation of globular inclusion structures 
is an intrinsic property of μNS.
The ability of μNS to redirect the subcellular localiza-
tions of other PRV proteins can be mediated through 
protein–protein interactions. This was observed for 
σNS and μ2 following immunoprecipitation and west-
ern blotting. Many cellular proteins are only functional 
when localized to specific cellular compartments, and 
translocation to the appropriate sites can serve to regu-
late protein function [36]. Reovirus proteins involved 
in replication are only active within functional centers 
characterized by a particular location and protein com-
position [36]. We could not demonstrate protein–pro-
tein interaction between μNS and λ1, although confocal 
imaging clearly proved redistribution of λ1 when the pro-
tein was co-expressed with μNS. Interaction(s) between 
μNS and λ1 is therefore likely but perhaps through the 
involvement of a third cellular protein. Alternatively, the 
binding affinities between the two proteins are below 
the threshold detectable by the conditions used in the 
Figure 5 Western blot of immunoprecipitated PRV proteins. 
Lysates from EPC cells transfected with µNS alone or µNS together 
with σNS, μ2 or λ1 were used for immunoprecipitation (IP) target-
ing the different protein tags. Their ability to co-precipitate µNS was 
assessed by western blotting targeting µNS (84.5 kDa).
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immunoprecipitation- and western blot assays. Fur-
ther investigations are needed to study the mechanisms 
involved in λ1 redistribution when co-expressed with 
μNS. Since μNS expressed alone forms viral factory-like 
inclusions, and is responsible for the redistribution of 
other PRV proteins, it is likely one of the first proteins 
involved in virus factory formation and thereby essential 
in the early steps of viral replication.
Staining of σNS, and to some extend μ2, was observed 
in the nucleus of transfected cells. The size of the σNS 
protein, predicted to be 39.1  kDa, may allow pas-
sive diffusion through the nuclear pores, whereas the 
86  kDa μ2 protein exceeds the 40  kDa limit for passive 
diffusion [39]. MRV σNS and μ2 are both shown to be 
distributed in the nucleus and the cytoplasm of trans-
fected and infected cells. The ability of MRV σNS to 
locate in the nucleus of infected cells has been linked to 
its nucleic acid binding capability, while the presence of 
MRV μ2 in the nucleus of transfected cells is explained 
by predicted nuclear import and export signals [20, 24, 
40–42]. There are no predicted classical nuclear localiza-
tion signals (NLSs) in PRV σNS [8] or PRV μ2 (present 
study, using PSORTII and NLS mapper). The presence of 
nuclear export signals (NES) have though been predicted 
for both proteins. Neither σNS nor μ2 was found in the 
nucleus after co-transfection with μNS. As μNS does not 
Figure 6 Co-transfections with truncated μNS variants. EPC cells transfected with pcDNA3.1-μNS-Δ743-752, pcDNA3.1-μNS-Δ736-752, 
pcDNA3.1-μNS-Δ1-401 and pcDNA3.1-μNS-Δ402-752 processed for fluorescence microscopy 48 hpt. A EPC cells expressing μNSΔ743-752 alone 
and co-expressed with σNS. B EPC cells expressing μNSΔ736-752 alone and co-expressed with σNS. C EPC cells expressing μNSΔ402-752 alone and 
co-expressed with σNS. D EPC cells expressing μNSΔ1-401 alone and co-expressed with σNS.
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localize to the nucleus, an explanation might be that μNS 
sequesters σNS and μ2 within the cytoplasmic inclusions, 
thus reducing the amount of free σNS and μ2 to enter the 
nucleus. This has also been proposed for MRV σNS and 
μ2 [20, 40]. Further studies are needed to excavate the 
functional roles of the observed nuclear localization of 
PRV σNS and μ2.
The C-terminal part of MRV μNS contains four distinct 
regions comprising 250 amino acids that are sufficient to 
form viral factories [29]. These regions include two pre-
dicted coiled-coil domains, a linker region between the 
coiled coils containing a putative zinc hook, and a short 
C-terminal tail [24]. PRV μNS may contain a coiled-coil 
motif in its C-terminal region [8]. A deletion of the eight 
C-terminal amino acids of MRV μNS results in diffusely 
distributed protein throughout the cytoplasm and the 
nucleus, suggesting that these amino acids are necessary 
for inclusion formation [29]. PRV μNS also contains a 
high α-helical content in its C-terminal region although 
the sequence identity to the homologous MRV protein is 
low [8]. In fact, the predicted secondary structure profiles 
of MRV and PRV μNS show significant similarities, high-
lighting the importance of conserving structural features 
over primary sequence for the function of homologues 
proteins across evolutionary lines. Still, the two C-termi-
nally truncated forms of μNS containing deletions of 10 
and 17 amino acids, respectively, formed viral factory-like 
structures when expressed in EPC cells, indicating that 
factory formation is not dependent on these amino acids. 
Deletion of the 401  N-terminal amino acids seemed to 
have some influence on the viral factory formation, but 
the protein still accumulated in granular structures and 
retained its ability to recruit σNS. Deletions of the 351 
C-terminal amino acids, on the other hand, resulted in 
diffusely distributed protein and absence of globular 
inclusions. This indicates that the C-terminal region of 
μNS is essential for factory formation. The N-terminal 
region of PRV μNS displays a somewhat higher level of 
secondary structure conservation when compared to 
MRV. In MRV, this region of μNS is crucial for interac-
tions with σNS, μ2, λ1 and λ2 [34, 38].
In conclusion, our results strongly suggest that PRV 
µNS protein is essential for factory formation and assem-
bly of viral proteins, similar to that of μNS of other 
orthoreoviruses. Further studies on both the structural 
and functional properties of PRV proteins can provide 
important information relating to disease development 
following PRV infections.
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